CFMC
CORT icon

Curbstone Financial Management Corp’s Corcept Therapeutics CORT Stock Holding History

Curbstone Financial Management Corp’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13,680
Closed -$1.14M – 204
2025
Q3 		$1.14M Sell
13,680
-200
-1% -$14.5K 0.22% 102
2025
Q2 		$1.02M Hold
13,880
– – 0.21% 108
2025
Q1 		$1.59M Hold
13,880
– – 0.33% 72
2024
Q4 		$699K Hold
13,880
– – 0.15% 134
2024
Q3 		$642K Hold
13,880
– – 0.14% 143
2024
Q2 		$451K Buy
+13,880
New +$380K 0.1% 175

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Curbstone Financial Management Corp's CORT Position: Q4 2025 in Review

Curbstone Financial Management Corp sold out of Corcept Therapeutics (CORT) in Q4 2025, closing a stake of 13,680 shares — an estimated $1.14M sold.

Curbstone Financial Management Corp first reported a position in CORT in Q2 2024 and held it in 6 quarters. The position peaked at $1.59M in Q1 2025. 389 funds tracked by Wall St. Rank hold CORT as of Q4 2025.

  • Curbstone Financial Management Corp reported no remaining Corcept Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Curbstone Financial Management Corp sold 13,680 Corcept Therapeutics shares in Q4 2025, an estimated $1.14M.
  • Curbstone Financial Management Corp first reported a position in Corcept Therapeutics in Q2 2024 and held it in 6 quarters.
  • Curbstone Financial Management Corp's Corcept Therapeutics position peaked at $1.59M in Q1 2025.
  • 389 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2025.

Based on Curbstone Financial Management Corp's 13F filing for Q4 2025, filed 23 Jan 2026.